Viewing Study NCT03418532


Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2025-12-25 @ 7:11 PM
Study NCT ID: NCT03418532
Status: TERMINATED
Last Update Posted: 2023-03-23
First Post: 2018-01-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: MP0250 DARPinĀ® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Sponsor: Molecular Partners AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module